Tolvaptan for Heart Failure Patients with Volume Overload-Reference-Cited by-同舟云学术

Tolvaptan for Heart Failure Patients with Volume Overload

Published:2011-05-03 Issue:S1 Volume:25 Page:1-4
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Hori Masatsugu

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10557-011-6298-4.pdf

Reference22 articles.

1. Japanese Circulation Society. Guidelines for the diagnosis and treatment of cardiovascular disease (Joint Study Gr oup Report 2004): guidelines for the diagnosis and treatment of chronic heart failure (revised 2005). http://www.j-circ.or.jp/guideline/pdf/JCS2005_matsuzaki_h.pdf . Accessed 27 Oct 2010.

2. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577–85.

3. Goldsmith SR, Gheorghiade M. Vasopressin antagonism in heart failure. J Am Coll Cardiol. 2005;46:1785–91.

4. Rivera-Santos A, Star R. Sodium: volume depletion and hyponatremia. In: Seldin D, Giebisch G, editors. Diuretic agents—clinical physiology and pharmacology. San Diego: Academic; 1997. p. 559–69.

5. Palmer BF. Potassium disturbances associated with the use of diuretics. In: Seldin D, Giebisch G, editors. Diuretic agents—clinical physiology and pharmacology. San Diego: Academic; 1997. p. 571–83.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QbD green analytical procedure for the quantification of tolvaptan by utilizing stability indicating UHPLC method;BMC Chemistry;2024-06-28

2. A rapid and sensitive LC–MS/MS-ESI method for the determination of tolvaptan and its two main metabolites in human plasma;Journal of Chromatography B;2016-08

3. Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites;Journal of Gastroenterology;2015-11-26

4. Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan;Journal of Gastroenterology;2015-02-18

5. Enantioselective analysis of tolvaptan in rat and dog sera by high-performance liquid chromatography and application to pharmacokinetic study;Journal of Chromatography B;2014-08